0001209191-21-053378.txt : 20210825 0001209191-21-053378.hdr.sgml : 20210825 20210825193517 ACCESSION NUMBER: 0001209191-21-053378 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210823 FILED AS OF DATE: 20210825 DATE AS OF CHANGE: 20210825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novack David F CENTRAL INDEX KEY: 0001573072 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 211208347 MAIL ADDRESS: STREET 1: 39 YORKSHIRE DR CITY: OAKLAND STATE: CA ZIP: 94618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 900 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 900 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-23 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001573072 Novack David F C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 900 EMERYVILLE CA 94608 0 1 0 0 President & COO Common Stock 2021-08-13 4 A 0 2500 3.3915 A 109899 D Common Stock 2021-08-23 4 M 0 4167 4.50 A 114066 D Common Stock 2021-08-24 4 S 0 10000 14.00 D 104066 D Warrant (Right to Buy) 4.50 2021-08-23 4 M 0 4167 D 2022-02-12 Common Stock 4167 0 D Represents 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 13, 2021 The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021. All shares were sold at $14.00 Warrants were issued in connection with a financing transaction dated August 12, 2019 and were immediately exercisable upon issuance and have an expiration date of February 12, 2022. Not applicable David Novack, by /s/ Justin Burgess, Attorney-in-Fact 2021-08-25